ArticleDrug design, development and therapy2026
Evidence Based on Sleep Disorder Exacerbating Postoperative Pain via Kynureninase.
Article in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Surgery is a frequently employed intervention for patients; however, 30-80% of patients report moderate to severe pain after surgery. Postoperative pain is affected by a variety of factors, with sleep disturbance being a critical modulating factor that exacerbates postoperative pain intensity. Kynureninase (KYNU), a key hydrolase in the kynurenine pathway that produces quinolinic acid, may link sleep disturbances to pain sensitization; however, the underlying mechanisms remain unclear. Methods: We obtained skin and blood samples from 40 abdominal surgery patients and performed whole-transcriptome sequencing. Through analysis of the intersecting gene sets between patients with adequate and inadequate analgesia, as well as between those with sleep disorder and normal sleep, we identified genes significantly linked to both sleep disorders and postoperative pain. We established an animal model by making a hind paw plantar incision in mice subjected to chronic sleep deprivation. We then performed behavioral tests, including the tail flick test and von Frey filaments, measured the expression of differentially expressed genes via real-time quantitative polymerase chain reaction and immunofluorescence, and validated the results using pharmacological and calcium imaging methods. Results: We found that sleep deprivation greatly exacerbated postoperative pain, and KYNU was notably higher in the skin, blood, and dorsal root ganglion (DRG). Repeated intraperitoneal injections of carbidopa, a KYNU modulator, reduced the severity of pain induced by sleep deprivation and abnormal excitability of DRG neurons. Furthermore, in preclinical models, carbidopa treatment effectively reduced both inflammatory and neuropathic pain. Conclusion: We conclude that the upregulated expression of KYNU is associated with the exacerbation of postoperative pain due to sleep deprivation and identified the compound carbidopa as possessing significant analgesic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.